Cambridge, United Kingdom

Verena Petzer

This inventor holds 1 USPTO granted patent. Top assignee: Kymab Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Verena Petzer. Retrieved from https://idiyas.com/inventor/verena-petzer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Verena Petzer: Innovator in Antagonist Development

Introduction

Verena Petzer is a notable inventor based in Cambridge, GB. She has made significant contributions to the field of biotechnology, particularly in the development of antagonists. With a strong academic background and a passion for innovation, she has secured her place in the world of patents.

Latest Patents

Verena holds 1 patent for her work on antagonists. This patent reflects her commitment to advancing scientific knowledge and improving therapeutic options in the medical field.

Career Highlights

Verena is currently employed at Kymab Limited, a company known for its pioneering work in antibody therapeutics. Her role at Kymab has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Throughout her career, Verena has worked alongside talented individuals such as Volker Germaschewski and Igor Theurl. These collaborations have enriched her research and expanded her impact in the biotechnology sector.

Conclusion

Verena Petzer is a remarkable inventor whose work in antagonists is paving the way for future innovations in medicine. Her dedication to research and collaboration exemplifies the spirit of innovation in the scientific community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…